Oxygenesis Hyperbaric Medicine LLC is categorized under Health Services in Athens, TN and active since 2010.
Oxygenesis Hyperbaric Medicine LLC was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Timothy Pysell at the company’s single location by writing to 285 County Road 707, Athens, Tennessee TN 37303 or by phoning (423) 503-3269. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oxygenesis Hyperbaric Medicine LLC |
| Contact Person: | Timothy Pysell |
| Address: | 285 County Road 707, Athens, Tennessee 37303 |
| Phone Number: | (423) 503-3269 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Oxygenesis Hyperbaric Medicine LLC was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Timothy Pysell for inquiries that concern Oxygenesis Hyperbaric Medicine LLC by calling the company number (423) 503-3269, as your correspondence is most welcome. Additionally, the physical location of the single location of Oxygenesis Hyperbaric Medicine LLC can be found at the coordinates 35.403774,-84.65045 as well as the street address 285 County Road 707 in Athens, Tennessee 37303.
For its online presence, you may visit Oxygenesis Hyperbaric Medicine LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.